(Q44899669)

7 December 2017

title

Impact of long-acting growth factors on practice dynamics and patient satisfaction (English)

1 reference

7 December 2017

1 reference

Roy A Beveridge

1

1 reference

7 December 2017

Robert M Rifkin

2

1 reference

7 December 2017

Ronald J Moleski

3

1 reference

7 December 2017

Gary Milkovich

4

1 reference

7 December 2017

John F Reitan

5

1 reference

7 December 2017

Thomas A Paivanas

6

1 reference

7 December 2017

R Jake Jacobs

7

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

7 December 2017

1 reference

7 December 2017

volume

23

1 reference

7 December 2017

issue

12 Pt 2

1 reference

7 December 2017

page(s)

101S-109S

1 reference

Biological basis of anemia

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.16.101S.31971

Chemotherapy-induced anemia in adults: incidence and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.16.101S.31971

Radiotherapy-associated anemia: the scope of the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.16.101S.31971

Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.16.101S.31971

The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.16.101S.31971

Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.16.101S.31971

A dose-finding and safety study of novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia in patients receiving multicycle chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.16.101S.31971

Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.16.101S.31971

Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.16.101S.31971

Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.16.101S.31971

Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.16.101S.31971

10.1592/PHCO.23.16.101S.31971

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference